Medicare Enrolled

Dr. Rana McKay, MD

Hematology & Oncology · San Diego, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
200 W ARBOR DR, San Diego, CA 92103
8009268273
In practice since 2008 (17 years)
NPI: 1306013610 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McKay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKay? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McKay

Dr. Rana McKay is a hematology & oncology specialist in San Diego, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. McKay performed 285 Medicare services across 204 unique beneficiaries.

Between the years covered by Open Payments, Dr. McKay received a total of $457,268 from 34 pharmaceutical and/or device companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McKay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 285 Medicare services $457,268 industry payments

Medicare Practice Summary

Medicare Utilization ↗
285
Medicare services
Bottom 24% in CA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
204
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
158 $75 $350
New patient office visit, complex (60-74 min) 37 $137 $674
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
36 $116 $484
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
21 $62 $307
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
19 $98 $355
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $143 $688
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$457,268
Total received (2018-2024)
Avg $65,324/year across 7 years
Top 2% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
320
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$296,423 (64.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159,705 (34.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,140 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$140,620
2023
$86,927
2022
$66,951
2021
$70,069
2020
$53,890
2019
$23,208
2018
$15,604

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$71,391
AstraZeneca UK Limited
$14,925
Bayer Healthcare Pharmaceuticals Inc.
$11,023
Daiichi Sankyo Inc.
$10,667
Novartis Pharmaceuticals Corporation
$6,800
E.R. Squibb & Sons, L.L.C.
$6,675
PFIZER INC.
$5,500
Exelixis Inc.
$5,264
AstraZeneca Pharmaceuticals LP
$2,663
Aveo Pharmaceuticals, Inc.
$2,220
Janssen Research & Development, LLC
$2,078
Janssen Scientific Affairs, LLC
$1,125
Sumitomo Pharma America, Inc.
$106
INTUITIVE SURGICAL, INC.
$97
Blue Earth Diagnostics Limited
$66
Eisai Inc.
$20
Top 3 companies account for 69.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$81,641
Exelixis Inc.
$57,205
PFIZER INC.
$43,712
E.R. Squibb & Sons, L.L.C.
$29,216
AstraZeneca UK Limited
$28,282
Bayer HealthCare Pharmaceuticals Inc.
$25,415
Merck Sharp & Dohme Corporation
$24,870
Bayer Healthcare Pharmaceuticals Inc.
$18,745
GENZYME CORPORATION
$17,832
Daiichi Sankyo Inc.
$14,105
AstraZeneca Pharmaceuticals LP
$12,978
Dendreon Pharmaceuticals LLC
$12,554
Astellas Pharma US Inc
$11,201
Novartis Pharmaceuticals Corporation
$10,738
NOVARTIS PHARMACEUTICALS CORPORATION
$9,566
Seagen Inc.
$7,036
AVEO Pharmaceuticals, Inc.
$6,135
Eli Lilly and Company
$5,400
Janssen Biotech, Inc.
$5,355
Aveo Pharmaceuticals, Inc.
$4,332
Janssen Research & Development, LLC
$4,278
Eisai Inc.
$4,243
Janssen Scientific Affairs, LLC
$4,090
Ipsen Pharma SAS
$3,488
Telix Pharmaceuticals
$3,200
Takeda Pharmaceutical Company, Limited
$3,043
Gilead Sciences, Inc.
$2,432
Blue Earth Diagnostics Limited
$2,016
Advanced Accelerator Applications
$1,712
Janssen Global Services, LLC
$1,650
SUN PHARMACEUTICAL INDUSTRIES INC.
$500
Sumitomo Pharma America, Inc.
$106
INTUITIVE SURGICAL, INC.
$97
Ethicon US, LLC
$93
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
BAVENCIO · CABOMETYX · COSENTYX · Cabometyx · Da Vinci Surgical System · ERLEADA · Echelon Flex · FOTIVDA · ILLUCCIX · INLYTA · JEVTANA · KEYTRUDA · LYNPARZA · Lenvima · MK-6482 · NO PRODUCT DISCUSSED · Non-Covered · Nubeqa · OPDIVO · ORGOVYX · PADCEV · PLUVICTO · POSLUMA · PROVENGE · TALZENNA · Trodelvy · VOTRIENT · WELIREG · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for hematology & oncology in CA.

Looking for a hematology & oncology specialist in San Diego?
Compare hematology & oncology specialists in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McKay is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 2% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McKay experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McKay performed 158 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKay receive payments from pharmaceutical companies?
Yes. Dr. McKay received a total of $457,268 from 34 companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKay's costs compare to other hematology & oncology specialists in San Diego?
Dr. McKay's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →